Loading…
A Novel SACS Variant Identified in a Chinese Patient: Case Report and Review of the Literature
Mutations in the gene have been linked to autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS). It is a clinically and genetically heterogeneous disease characterized by slow progressive ataxia, spasticity, sensorimotor neuropathy, and a combination of other manifestations, such as lac...
Saved in:
Published in: | Frontiers in neurology 2022-03, Vol.13, p.845318 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Mutations in the
gene have been linked to autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS). It is a clinically and genetically heterogeneous disease characterized by slow progressive ataxia, spasticity, sensorimotor neuropathy, and a combination of other manifestations, such as lack of spasticity, hearing loss, and epileptic seizures. Currently, there have been very few case reports regarding the
gene mutation in Chinese patients. Here, we describe a 35-year-old Chinese patient carrying a novel variant in
(c.11486C>T) presenting with progressive ataxia and demyelinating peripheral neuropathy. We then reviewed 22 Chinese cases carrying
gene mutations, including our patient. All of them had a cerebellar ataxia gait and showed cerebellar atrophy on brain magnetic resonance imaging (MRI). A total of 28
mutations were identified in these patients. Our study further expands the mutation spectrum of the
gene and contributes to the evaluation of genotype-phenotype correlations. |
---|---|
ISSN: | 1664-2295 1664-2295 |
DOI: | 10.3389/fneur.2022.845318 |